DE3768150D1 - Verwendung eines 1,3-oxazolidin-2-on-derivates zur herstellung eines arzneimittels zur behandlung von ischaemie. - Google Patents

Verwendung eines 1,3-oxazolidin-2-on-derivates zur herstellung eines arzneimittels zur behandlung von ischaemie.

Info

Publication number: DE3768150D1
Authority: DE; Germany
Prior art keywords: oxazolidin; derivate; producing; medicinal product; treating ischaemia
Prior art date: 1986-06-18
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

DE8787305418T

Other languages

English (en)

Inventor

Kyuya Kogure

Mitsuo Masaki

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Nippon Chemiphar Co Ltd

Original Assignee

Nippon Chemiphar Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-06-18

Filing date

1987-06-18

Publication date

1991-04-04

1987-06-18 Application filed by Nippon Chemiphar Co Ltd filed Critical Nippon Chemiphar Co Ltd

1991-04-04 Application granted granted Critical

1991-04-04 Publication of DE3768150D1 publication Critical patent/DE3768150D1/de

2007-06-19 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Urology & Nephrology (AREA)
Hospice & Palliative Care (AREA)
Vascular Medicine (AREA)
Psychiatry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

DE8787305418T 1986-06-18 1987-06-18 Verwendung eines 1,3-oxazolidin-2-on-derivates zur herstellung eines arzneimittels zur behandlung von ischaemie. Expired - Fee Related DE3768150D1 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP14159386		1986-06-18
JP1387687		1987-01-23
JP62136460A JPH0713017B2 (ja)	1986-06-18	1987-05-30	脳細胞保護作用を有する医薬組成物

Publications (1)

Publication Number	Publication Date
DE3768150D1 true DE3768150D1 (de)	1991-04-04

Family

ID=27280439

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE8787305418T Expired - Fee Related DE3768150D1 (de)	1986-06-18	1987-06-18	Verwendung eines 1,3-oxazolidin-2-on-derivates zur herstellung eines arzneimittels zur behandlung von ischaemie.

Country Status (7)

Country	Link
US (1)	US4804657A (de)
EP (1)	EP0250241B1 (de)
JP (1)	JPH0713017B2 (de)
AU (1)	AU603363B2 (de)
DE (1)	DE3768150D1 (de)
DK (1)	DK308187A (de)
NZ (1)	NZ220747A (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE106243T1 (de) *	1988-03-24	1994-06-15	Sankyo Co	Verwendung von isoxazolinonen als cerebro-aktive medikamente.
US5066662A (en) *	1990-05-21	1991-11-19	Warner-Lambert Company	Substituted oxazolidin-2-ones and 1,2,4-oxadiazolin-5-ones and derivatives thereof acting at muscarinic receptors
DE4324393A1 (de) *	1993-07-21	1995-01-26	Merck Patent Gmbh	4-Aryloxy- und 4-Arylthiopiperidinderivate
DE19531321A1 (de) *	1995-08-25	1997-02-27	Merck Patent Gmbh	Piperidinylmethyloxazolidinone
AU740064B2 (en) *	1997-06-18	2001-10-25	H. Lundbeck A/S	Heterocyclic substituted piperidines and uses thereof
US6159990A (en) *	1997-06-18	2000-12-12	Synaptic Pharmaceutical Corporation	Oxazolidinones as α1A receptor antagonists
US6228870B1 (en)	1998-11-10	2001-05-08	Merck & Co., Inc.	Oxazolidinones useful as alpha 1a adrenoceptor antagonists
US6319932B1 (en)	1998-11-10	2001-11-20	Merck & Co., Inc.	Oxazolidinones useful as alpha 1A adrenoceptor antagonists
US20050032858A1 (en) *	2001-10-03	2005-02-10	Masae Takagi	Novel heterocyclic compound and anti-inflamatory agent
US20160152579A1 (en) *	2013-07-11	2016-06-02	Servicio Andaluz De Salud	Oxazolidinone derivatives as ppar ligands

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS6183170A (ja) *	1984-09-28	1986-04-26	Nippon Chemiphar Co Ltd	新規な１，３−オキサゾリジン−２−オン誘導体およびその製造法

1987
- 1987-05-30 JP JP62136460A patent/JPH0713017B2/ja not_active Expired - Lifetime
- 1987-06-17 DK DK308187A patent/DK308187A/da not_active Application Discontinuation
- 1987-06-18 NZ NZ220747A patent/NZ220747A/xx unknown
- 1987-06-18 EP EP87305418A patent/EP0250241B1/de not_active Expired - Lifetime
- 1987-06-18 DE DE8787305418T patent/DE3768150D1/de not_active Expired - Fee Related
- 1987-06-18 US US07/063,379 patent/US4804657A/en not_active Expired - Fee Related
- 1987-06-18 AU AU74484/87A patent/AU603363B2/en not_active Ceased

Also Published As

Publication number	Publication date
NZ220747A (en)	1990-07-26
EP0250241B1 (de)	1991-02-27
AU7448487A (en)	1987-12-24
AU603363B2 (en)	1990-11-15
DK308187D0 (da)	1987-06-17
JPS63301819A (ja)	1988-12-08
DK308187A (da)	1987-12-19
US4804657A (en)	1989-02-14
EP0250241A1 (de)	1987-12-23
JPH0713017B2 (ja)	1995-02-15

Similar Documents

Publication	Publication Date	Title
DE3585607D1 (de)	1992-04-16	Verwendung von paroxetine zur herstellung eines arzneimittel zur behandlung von obesitaet.
DE59100830D1 (de)	1994-02-24	Verfahren zur Herstellung von 3-Aminomethyl-3,5,5,-trimethyl-cyclohexylamin.
DE3887625D1 (de)	1994-03-17	Verfahren zur Herstellung von 1,1,1-Trifluorodichlorethan und von 1,1,1,2-Tetrafluorchlorethan.
DE3889393D1 (de)	1994-06-09	Verfahren zur Herstellung von 2,2,6,6-Tetramethyl-4-piperidylaminen.
DE68927703D1 (de)	1997-03-06	Verfahren zur Herstellung von 2,3-Dimethylbutenen
DE3484055D1 (de)	1991-03-07	Verwendung von ubidecarenon zur herstellung eines medikaments zur behandlung von durch radiotherapie hervorgerufenen geschwueren.
DE3785740D1 (de)	1993-06-09	Verwendung von carboxamid-verbindungen zur herstellung eines arzneimittels zur behandlung der hyperlipaemie.
DE59003791D1 (de)	1994-01-20	Verfahren zur Herstellung von 1,3,3-Trimethyl-5-oxo-cyclohexan-carbonitril.
DE3768150D1 (de)	1991-04-04	Verwendung eines 1,3-oxazolidin-2-on-derivates zur herstellung eines arzneimittels zur behandlung von ischaemie.
ATA232687A (de)	1991-06-15	Zahnpflegemittel, sowie verfahren zur herstellung des zahnpflegemittels
DE69006911D1 (de)	1994-04-07	Verfahren zur Herstellung von 3,4-Dichloranilin.
DE3675115D1 (de)	1990-11-29	Verwendung von verbindungen zur herstellung eines medikaments fuer die behandlung von grauem star.
ATE135220T1 (de)	1996-03-15	Verwendung von 1-alpha,24(r)-dihydroxy-22(e)- dehydrovitamin-d3 zur herstellung eines arzneimittels zur behandlung der osteoporose
DE69013429D1 (de)	1994-11-24	Verfahren zur Herstellung von 2,2-Dimethyl-3-hydroxypropyl-2,2-dimethyl-3-hydroxypropionat.
DE68905657D1 (de)	1993-05-06	Verwendung von arginin-aspartat zur herstellung eines arzneimittels zur behandlung gewisser gedaechtnisstoerungen.
DE3686097D1 (de)	1992-08-27	Verwendung von dopamin-agonisten zur herstellung eines arzneimittels zur behandlung von psychostimulant-sucht.
ATE101846T1 (de)	1994-03-15	Verfahren zur herstellung von 1,1dichlorotetrafluorethan.
DE69007637D1 (de)	1994-05-05	Verfahren zur Herstellung von 1,1,3,4,4,6-Hexamethyl-1,2,3,4-tetrahydronaphthalin.
DE3873210D1 (de)	1992-09-03	Verwendung von benzylpyridin-derivaten zur herstellung eines arzneimittels zur behandlung der demenz.
DE68922507D1 (de)	1995-06-14	Verfahren zur Herstellung von beta-2',2'-Difluornukleosiden.
DE3887212D1 (de)	1994-03-03	Verfahren zur Herstellung von Derivaten von 6,7-Diazyl-7-desacetylforskolin.
DE59106607D1 (de)	1995-11-09	Verfahren zur Herstellung von 2,2-disubstituierten Pentan-1,5-diaminen.
DE3873188D1 (de)	1992-09-03	Verwendung von nigerizin zur herstellung eines mittels zur behandlung von virus-erkrankungen.
DE69009394D1 (de)	1994-07-07	Verfahren zur Herstellung von 3-Cyano-3,5,5-trimethyl-1-cyclohexanon.
DE3784768D1 (de)	1993-04-22	Verwendung von zusammensetzungen auf basis von crotoxin, zur herstellung von medikamenten zur behandlung von carcinomen.

Legal Events

Date	Code	Title	Description
1992-03-26	8364	No opposition during term of opposition
2001-08-09	8339	Ceased/non-payment of the annual fee